no statement of use filed
on 02 Oct 2023
Last Applicant/ Owned by
55 Cambridge Parkway, Suite 800E
Cambridge
MA
02142
Serial Number
88744777 filed on 02th Jan 2020
Registration Number
N/A
Correspondent Address
Christina M. Licursi, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, muscul Read More
encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy
N/A
N/A
No 88744777
No Service/Collective Mark
No V03222000700
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
02th Oct 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
02th Oct 2023 | ABANDONMENT - NO USE STATEMENT FILED |
10th Mar 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
09th Mar 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
09th Mar 2023 | SOU EXTENSION 5 GRANTED |
24th Feb 2023 | SOU EXTENSION 5 FILED |
24th Feb 2023 | SOU TEAS EXTENSION RECEIVED |
01st Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
30th Aug 2022 | SOU EXTENSION 4 GRANTED |
30th Aug 2022 | SOU EXTENSION 4 FILED |